Works matching IS 2574173X AND DT 2019 AND VI 39 AND IP 4

Results: 9

Therapy‐refractory schizophrenia in a patient who previously suffered from Meige's syndrome.
Published in:
Neuropsychopharmacology Reports, 2019, v. 39, n. 4, p. 297, doi. 10.1002/npr2.12081
By:
- Uemura, Tomihiko;
- Mochida, Masahiko;
- Matsumi, Tatsunaru;
- Yoshimoto, Katsuhiko;
- Tatebayashi, Yoshitaka
Publication type:
Article
GABAergic function in the lateral hypothalamus regulates feeding behavior: Possible mediation via orexin.
Published in:
Neuropsychopharmacology Reports, 2019, v. 39, n. 4, p. 289, doi. 10.1002/npr2.12080
By:
- Yonemochi, Naomi;
- Ardianto, Chrismawan;
- Ueda, Daiki;
- Kamei, Junzo;
- Ikeda, Hiroko
Publication type:
Article
Bee honey protects astrocytes against oxidative stress: A preliminary in vitro investigation.
Published in:
Neuropsychopharmacology Reports, 2019, v. 39, n. 4, p. 312, doi. 10.1002/npr2.12079
By:
- Ali, Amira Mohammed;
- Kunugi, Hiroshi
Publication type:
Article
Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second‐generation antidepressants: Study protocol for a randomized, parallel‐group, non‐inferiority trial.
Published in:
Neuropsychopharmacology Reports, 2019, v. 39, n. 4, p. 262, doi. 10.1002/npr2.12078
By:
- Yokoi, Yuma;
- Nakagawa, Atsuo;
- Yoshimura, Naoki;
- Furukawa, Toshiaki A.;
- Mimura, Masaru;
- Iwanami, Akira;
- Abe, Takayuki;
- Nakagome, Kazuyuki
Publication type:
Article
Effects of iso‐α‐acids, the hop‐derived bitter components in beer, on the MRI‐based Brain Healthcare Quotient in healthy middle‐aged to older adults.
Published in:
Neuropsychopharmacology Reports, 2019, v. 39, n. 4, p. 273, doi. 10.1002/npr2.12077
By:
- Kita, Masahiro;
- Yoshida, Satoshi;
- Kondo, Keiji;
- Yamakawa, Yoshinori;
- Ano, Yasuhisa
Publication type:
Article
Brexpiprazole has a low risk of dopamine D2 receptor sensitization and inhibits rebound phenomena related to D2 and serotonin 5‐HT2A receptors in rats.
Published in:
Neuropsychopharmacology Reports, 2019, v. 39, n. 4, p. 279, doi. 10.1002/npr2.12076
By:
- Amada, Naoki;
- Akazawa, Hitomi;
- Ohgi, Yuta;
- Maeda, Kenji;
- Sugino, Haruhiko;
- Kurahashi, Nobuyuki;
- Kikuchi, Tetsuro;
- Futamura, Takashi
Publication type:
Article
Evaluation of the usefulness of saliva for DNA methylation analysis in cohort studies.
Published in:
Neuropsychopharmacology Reports, 2019, v. 39, n. 4, p. 301, doi. 10.1002/npr2.12075
By:
- Murata, Yui;
- Fujii, Ayaka;
- Kanata, Sho;
- Fujikawa, Shinya;
- Ikegame, Tempei;
- Nakachi, Yutaka;
- Zhao, Zhilei;
- Jinde, Seiichiro;
- Kasai, Kiyoto;
- Bundo, Miki;
- Iwamoto, Kazuya
Publication type:
Article
Induced neuronal activity does not attenuate amyloid beta‐induced synaptic loss in vitro.
Published in:
Neuropsychopharmacology Reports, 2019, v. 39, n. 4, p. 306, doi. 10.1002/npr2.12074
By:
- Kono, Rena;
- Kim, Gyu Li;
- Nagata, Hidetaka;
- Ikegaya, Yuji;
- Koyama, Ryuta
Publication type:
Article
Issue Information.
Published in:
Neuropsychopharmacology Reports, 2019, v. 39, n. 4, p. 261, doi. 10.1002/npr2.12024
Publication type:
Article